OSI Pharmaceuticals

Drug makers pay $67m for misleading docs about cancer drug survival data
Stat
Mon, 06/6/16 - 11:21 pm
Roche
Genentech
OSI Pharmaceuticals
False Claims Act
whistleblower lawsuits
Tarceva
non-small cell lung cancer
A Few Hundred More Pharma Jobs Are Being Cut
Pharmalot
Wed, 05/15/13 - 10:43 am
layoffs
Purdue Pharma
Astellas
OSI Pharmaceuticals
Intermezzo
contract reps
Pfizer, OSI Sue Roxane Over Generic Tarceva Cancer Drug
Bloomberg
Sat, 04/14/12 - 12:36 pm
Pfizer
OSI Pharmaceuticals
Astellas' patent sale gins $609M for new round of dealmaking
Fierce Biotech
Thu, 06/30/11 - 09:36 am
Astellas
patents
diabetes
OSI Pharmaceuticals
Aveo's Coming Out Party
Minyanville
Thu, 12/2/10 - 09:38 am
Aveo Pharmaceutical
Astellas
OSI Pharmaceuticals
Biggest Battles in Biopharma
Fierce Pharma
Wed, 09/8/10 - 11:33 am
Sun Pharma
Taro
Pfizer
Warner-Lambert
Aventis
Sanofi-Synthelabo
Astellas
OSI Pharmaceuticals
King
Alpharma
Novartis
Carl Icahn
Bristol-Myers Squibb
Alcon
Genzyme
Astellas Cuts Profit Outlook, Says Earnings May Fall Further on OSI Costs
Bloomberg
Mon, 08/2/10 - 10:22 am
earnings
Astellas
M&A
OSI Pharmaceuticals
OSI Pharmaceuticals Announces the Results of its Offer to Purchase its 2% Convertible Notes and a Change in the Expiration Time of its Offer to Purchase its 3% Convertible Notes
MarketWatch
Tue, 07/13/10 - 08:58 pm
OSI Pharmaceuticals
Astellas Seals the Deal With OSI After Rocky Courtship
Seeking Alpha
Sun, 05/23/10 - 11:27 am
Astellas
OSI Pharmaceuticals
M&A
Big Pharma's Romance With Biotech Still Smolders, Despite Its Cold Shoulder to OSI
BNET Pharma
Wed, 05/19/10 - 11:20 am
OSI Pharmaceuticals
Big Pharma
Astellas
Roche
Gilead Sciences
CV Therapeutics
Astellas Finally Joins Peers With Major Overseas Acquisition
Seeking Alpha
Tue, 05/18/10 - 10:05 am
Astellas
OSI Pharmaceuticals
M&A
Astellas May Stem Drug-Sales Drop With OSI Purchase
Bloomberg
Tue, 05/18/10 - 09:41 am
Astellas
OSI Pharmaceuticals
M&A
Astellas Raises Offer for OSI Pharma to $4 Billion
Bloomberg
Mon, 05/17/10 - 09:41 am
Astellas
OSI Pharmaceuticals
M&A
Alkermes leads drug stocks south; OSI gains
MarketWatch
Sat, 05/15/10 - 11:37 am
biotech. Alkermes
OSI Pharmaceuticals
Astellas Extends Offer Deadline for OSI a Second Time
Bloomberg
Fri, 04/23/10 - 07:47 am
Astellas
OSI Pharmaceuticals
M&A
Better, Targeted Drugs, Dead Ahead
Motley Fool
Wed, 04/21/10 - 07:53 am
personalized medicine
Vectibix
Amgen
Novartis
Bristol-Myers Squibb
Eli Lilly
OSI Pharmaceuticals
ONYX Pharmaceuticals
Roche
Astellas Won’t Raise OSI Bid on FDA Decision Alone
Bloomberg
Mon, 04/19/10 - 11:01 am
Astellas
FDA
OSI Pharmaceuticals
M&A
FDA Approves Tarceva as a Maintenance Therapy for Advanced Non-Small Cell Lung Cancer
Yahoo/BusinessWire
Sat, 04/17/10 - 12:23 pm
Tarceva
OSI Pharmaceuticals
non-small cell lung cancer
SATURN
Wall Street sees Astellas nabbing OSI for up to $4.3B
Fierce Pharma
Wed, 04/14/10 - 10:48 am
OSI Pharmaceuticals
Astellas
M&A
Seven Biotech Drugs to Watch in the Second Quarter
BNET Pharma
Tue, 04/13/10 - 10:35 am
Acorda Therapeutics
AMPYRA
Cell Therapeutics
pixantrone
Pixuvri
Dendreon
Provenge
InterMune
Esbriet
Pozen
Vimovo
XenoPort
Horizant
Astellas
OSI Pharmaceuticals
Ironwood

Pages